Bacterial and Fungal Keratitis in a Tertiary Care Hospital from Romania

Author:

Bălășoiu Andrei Theodor12,Bălășoiu Maria34,Zlatian Ovidiu Mircea34ORCID,Ghenea Alice Elena34ORCID

Affiliation:

1. Ophtalmology Department, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania

2. Ophtalmology Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

3. Medical Laboratory, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania

4. Microbiology Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Abstract

Infectious keratitis is a significant global problem that can lead to corneal blindness and visual impairments. This study aimed to investigate the etiology of infectious bacterial and fungal keratitis, identify the causative pathogens and their antimicrobial resistance patterns, and analyze the risk factors associated with the development of infectious keratitis. The study was observational and retrospective, involving 226 eyes from 223 patients presented at the Ophthalmology Clinic of the County Clinical Emergency Hospital of Craiova, Romania. The inclusion criteria included corneal ulceration/abscess/infiltrate present on slit-lamp examination and positive microbiological sampling for bacteria or fungi. The study found that the most common causes of infectious keratitis were coagulase-negative staphylococci (35.40%), Staphylococcus aureus (11.06%), and Pseudomonas aeruginosa (14.16%). The Gram-positive bacteria showed high resistance rates to penicillin, moderate rates to gentamycin and clindamycin, and low resistance to chinolones. The Gram-negative bacteria were highly resistant to ampicillin and amoxicillin–clavulanic acid, while third-generation cephalosporins, quinolones, and carbapenems were effective. Systemic antibiotics, such as vancomycine, piperacillin–tazobactam, amikacin, and ceftazidime, show promise against keratitis with low resistance rates, whereas carbapenems and topical aminoglycosides had higher resistance, leaving moxifloxacin as a potential topical option for Gram-positive bacteria and Pseudomonas aeruginosa, albeit with resistance concerns for Klebsiella spp. Although fungal keratitis was rare, Fusarium spp. and Candida albicans were the leading fungal pathogens, with incidences of 2.65% and 2.21%, respectively. Candida albicans was broadly susceptible to most antifungals, while Fusarium solani, Curvularia lunata, and Alternaria alternata exhibited resistance to many antifungals. Amphotericin B and caspofungin can be used as systemic antifungals in fungal keratitis. The study also identified risk factors for keratitis such as ocular trauma (65.92%, OR: 2.5), contact lens wear (11.94%, OR: 1.8), and corneal scarring/leukoma (10.17%, OR: 1.6). Keratitis was more frequent in individuals over 60 years old. The findings of this study have implications for the development of effective diagnostic, therapeutic, and preventive strategies for infectious keratitis.

Funder

University of Medicine and Pharmacy of Craiova

Publisher

MDPI AG

Reference62 articles.

1. The Welleye: A Conceptual Framework for Understanding and Promoting Wellbeing;Dolan;Front. Psychol.,2021

2. Ravilla, T., Karumanchi, S., and Das, T. (2021). South-East Asia Eye Health, Springer.

3. The Lancet Global Health Commission on Global Eye Health: Vision beyond 2020;Burton;Lancet Glob. Health,2021

4. Eye Health and Quality of Life: An Umbrella Review Protocol;Assi;BMJ Open,2020

5. Martines, E., Reitberger, H., Chow, C., Brun, P., Zuin, M., and Fuchsluger, T.A. (2018). Comprehensive Clinical Plasma Medicine: Cold Physical Plasma for Medical Application, Springer.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3